Cargando…
miRNA signature associated with outcome of gastric cancer patients following chemotherapy
BACKGROUND: Identification of patients who likely will or will not benefit from cytotoxic chemotherapy through the use of biomarkers could greatly improve clinical management by better defining appropriate treatment options for patients. microRNAs may be potentially useful biomarkers that help guide...
Autores principales: | Kim, Chang Hee, Kim, Hark K, Rettig, R Luke, Kim, Joseph, Lee, Eunbyul T, Aprelikova, Olga, Choi, Il J, Munroe, David J, Green, Jeffrey E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287139/ https://www.ncbi.nlm.nih.gov/pubmed/22112324 http://dx.doi.org/10.1186/1755-8794-4-79 |
Ejemplares similares
-
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection
por: Kim, Hark Kyun, et al.
Publicado: (2011) -
A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
por: Kim, Hark Kyun, et al.
Publicado: (2011) -
Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage
por: Zhu, Min, et al.
Publicado: (2011) -
Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021) -
Signature miRNAs in peripheral blood monocytes of patients with gastric or breast cancers
por: Shu, Le, et al.
Publicado: (2018)